Quite a double edged sword, on one hand it's positive that directors and big investors are backing the stock, however how many more times do we need to be diluted??
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025